Mesirow Financial Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Hold
4,939
0.01% 379
2026
Q1
$396K Sell
4,939
-3
-0.1% -$247 0.01% 388
2025
Q4
$421K Sell
4,942
-185
-4% -$15.2K 0.01% 350
2025
Q3
$399K Hold
5,127
0.01% 402
2025
Q2
$401K Buy
5,127
+93
+2% +$6.94K 0.01% 395
2025
Q1
$365K Sell
5,034
-48
-0.9% -$3.44K 0.01% 412
2024
Q4
$376K Hold
5,082
0.01% 412
2024
Q3
$335K Hold
5,082
0.01% 429
2024
Q2
$469K Hold
5,082
0.01% 337
2024
Q1
$486K Sell
5,082
-9,254
-65% -$777K 0.01% 342
2023
Q4
$1.09M Buy
+14,336
New +$998K 0.04% 213

Other funds holding EW

Mesirow Financial Investment Management's EW Position: Q2 2026 in Review

Mesirow Financial Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 4,939 shares worth $447K. The position accounts for 0.01% of the portfolio, ranked #379.

Mesirow Financial Investment Management first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.09M in Q4 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mesirow Financial Investment Management held 4,939 shares of Edwards Lifesciences worth $447K as of Q2 2026.
  • Mesirow Financial Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #379 holding.
  • Mesirow Financial Investment Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Edwards Lifesciences position peaked at $1.09M in Q4 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.